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Focal adhesionThe type I phosphatidylinositol 4-phosphate 5-kinase (PIP5K) family members and their lipid product,
phosphatidylinositol 4,5-bisphosphate (PIP2) are important regulators of actin cytoskeleton. PIP5Kγ 90 kDa
(PIP5Kγ90), an isoform of PIP5K, localizes to focal adhesions (FAs) and is activated via its interaction with the
cytoskeletal protein, talin. Currently, regulatory signaling pathways of talin–PIP5Kγ90 interaction related to FA
dynamics and cell motility are not well understood. Considering the presence of Akt consensus motifs in
PIP5Kγ90, we examined a potential link of Akt activation to talin–PIP5Kγ90 interaction. We found that Akt
phosphorylated PIP5Kγ90 speciﬁcally at serine 555 (S555) in vitro and in epidermal growth factor (EGF)-treated
cells phosphoinositide 3-kinase-dependently. EGF treatment suppressed talin–PIP5Kγ90 interaction and PIP2
levels. Similarly, a phosphomimetic mutant (S555D), but not non-phosphorylatable mutant (S555A), of
PIP5Kγ90had reduced talin binding afﬁnity, lowered PIP2 levels, andwas dislocated from FAs. The S555Dmutant
also caused decreases in actin stress ﬁbers and vinculin-positive FAs. Moreover, assembly and disassembly of FAs
were enhanced by S555D expression and EGF-induced cell migration was relatively low in S555A-expressing
cells compared to wild-type-expressing cells. PIP5Kγ87, a PIP5Kγ splice variant lacking the talin binding motif,
was phosphorylated by Akt, which, however, hardly affected PIP2 levels. Taken together, our results suggested
that Akt-mediated PIP5Kγ90 S555 phosphorylation is a novel regulatory point for talin binding to control PIP2
level at the FAs, thereby modulating FA dynamics and cell motility.
© 2015 Elsevier B.V. All rights reserved.1. Introduction
The phosphorylated derivatives of phosphatidylinositol called
phosphoinositides are important lipid regulators of many physiological
events [1,2]. In particular, phosphatidylinositol 4,5-bisphosphate (PIP2)
serves as a precursor for generation of lipid second messengers such as
phosphatidylinositol 3,4,5-trisphosphate (PIP3) by class I phospho-
inositide 3-kinase (PI3K), and diacylglycerol and inositol 1,4,5-trisphos-
phate by phosphoinositide-dependent phospholipase C (PLC). In
addition, PIP2 itself has pleiotropic effects on membrane signaling,
trafﬁcking, and dynamics by binding and modulating a number ofFAs, focal adhesions; PIP2,
hatidylinositol 4-phosphate 5-
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, sunghoe@snu.ac.kr (S. Chang),cytosolic proteins [3,4]. PIP2 is relatively enriched in the plasma mem-
brane and produced mainly by type I phosphatidylinositol 4-phosphate
5-kinase (PIP5K) catalyzing phosphorylation of phosphatidylinositol 4-
phosphate [3,5]. Most mammalian cells express PIP5K family members
consisting of PIP5Kα, PIP5Kβ, and PIP5Kγ isoforms [5–7]. Human
PIP5Kγ isoform has 2 splice variants, PIP5Kγ87 (1–640 amino acids,
87 kDa) and PIP5Kγ90 (1–668 amino acids, 90 kDa) depending on the
absence or presence of an additional 28 amino acids at the COOH-
terminal end [7,8].
PIP5Kγ90 speciﬁcally localizes to focal adhesions (FAs), the macro-
molecular assembled structures where cells attach to extracellular
matrix linked to actin cytoskeleton [8,9]. Diverse cytoskeletal and
signalingproteins, including integrins, talin, vinculin, and focal adhesion
kinase (FAK), comprise FAs. The recruitment of these proteins to FAs
and their physical interactions are closely associated with regulation
of formation and turnover of FAs, and consequently cell migration [10,
11]. Talin is an important adaptor to couple β-integrin to ﬁlamentous
actin (F-actin), and also binds vinculin. The binding of talin to the cyto-
plasmic tail of β-integrins induces the inside-out activation of integrin
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[12–14]. In addition, talin mediates interaction with PIP5Kγ90 via its
NH2-terminal band 4.1/ezrin/radixin/moesin (FERM) domain compris-
ing 3 subdomains (F1, F2, and F3). More speciﬁcally, the F3 subdomain
binds the COOH-terminal 28-amino acid tail (641–668) of PIP5Kγ90,
and the talin binding to PIP5Kγ90 not only acts to recruit PIP5Kγ90 to
FAs but also to stimulate its lipid kinase activity leading to an increase
in PIP2 levels [8]. PIP5Kγ87 lacking the 28-amino acid tail does not
bind talin, and consequently does not localize to FAs [8,9].
The binding of PIP2 to cytoskeletal proteins such as talin and vinculin
activates them by inducing conformational changes, thereby mediating
integrin activation at sites of cell adhesion [10,15,16]. Accumulating
evidence suggests that PIP5Kγ90 is mainly responsible for production
of functional PIP2 on membrane microdomains associated with FAs
[17–20]. On the other hand, PIP5Kγ90 and integrin compete with each
other for talin binding on its F3 subdomain [21,22]. The interaction
between talin and PIP5Kγ90 is thus required to be tightly controlled
during FA dynamics. Furthermore, PIP2 also binds and activates various
proteins, including WASP (Wiskott–Aldrich syndrome protein),
gelsolin, coﬁlin/ADF (actin-depolymerizing factor), and proﬁlin, that
regulate the processes of actin ﬁlament polymerization [23,24]. These
observations strongly indicate that regulation of the PIP5Kγ90-
dependent PIP2 pool is a signiﬁcant factor for actin cytoskeletal rear-
rangement at the plasma membrane underlying cell adhesion and
motility.
The local PIP2 production by PIP5Kγ90 is also critical for neurotrans-
mission at neuronal synapses [25]. Talin showed a presynaptic localiza-
tion and its interaction with PIP5Kγ90 had a functional implication in
synaptic vesicle recycling and actin dynamics [26]. PIP5Kγ90 undergoes
protein phosphorylation like many other nerve terminal proteins,
implying that multiple protein kinases are involved in regulation of
PIP5Kγ90 [27–29]. Previously, proline-directed protein kinases such as
cyclin-dependent kinase 5 (Cdk5) strongly inhibit talin binding by
phosphorylating PIP5Kγ90 [28]. In a similar context, we were intrigued
by the presence of the COOH-terminal PIP5Kγ90 sequence, R-Y-R-R-R-
T-Q-S (548–555 amino acids) that matches the Akt consensus motif,
R-X-R-X-X-T/S (X is any amino acid) [30], but is absent in both
PIP5Kα and PIP5Kβ. This is suggestive of serine/threonine kinase Akt
(also called protein kinase B)-mediated PIP5Kγ90 phosphorylation.
Akt activation inmammalian cells requires PIP3 formation fromPIP2
by class I PI3K in the plasma membrane, which induces membrane
recruitment of Akt and its upstream regulator phosphoinositide-
dependent kinase [31]. The binding of soluble ligands such as growth
factors to their cell surface receptors induces activation of PI3K/Akt
signaling. Thus, PI3K/Akt pathway plays an important role in growth
factor signal transduction for cell growth, proliferation, survival, and
differentiation [32]. Growing evidence also implicates PI3K/Akt signal-
ing in modulation of cell motility, invasion, and metastasis in various
cancers [31,32]. PI3K signaling is involved in integrin-mediated Akt
activation and actin polymerization [33], and Akt1-mediated phosphor-
ylation and activation of FAK contributed to growth factor-induced cell
migration and FA disassembly [34].
Given the important role of PIP5Kγ90 and PIP2 in cytoskeletal
remodeling at FAs, it is likely that regulation of PIP5Kγ90 catalytic activity
by talin binding affects FA dynamics, but details of the mechanism
remain largely unknown. We accordingly investigated whether Akt-
mediated phosphorylation of PIP5Kγ90 regulates talin–PIP5Kγ90 inter-
action. We treated HeLa cell cultures with epidermal growth factor
(EGF) thus activating endogenous PI3K/Akt signaling. We found that
the serine 555 residue in PIP5Kγ90 is phosphorylated by Akt upon
EGF stimulation, which inhibited its interaction with talin and FA local-
ization, leading to a decrease in PIP2 levels. We also showed that the
phosphomimetic mutant (S555D) could reduce actin stress ﬁbers and
vinculin-positive FAs and furthermore promoted FA disassembly. EGF-
induced cell migration was more signiﬁcant in PIP5Kγ90 wild-type-
expressing cells than in its S555A mutant-expressing cells. Overall,our results indicated that the Akt-dependent PIP5Kγ90 phosphoryla-
tion plays a role in modulating FA dynamics and cell motility through
regulation of the talin binding.
2. Materials and methods
2.1. Reagents and antibodies
Most chemicals, including EGF, DMEM, BSA, ﬁbronectin, paraformal-
dehyde, poly-L-lysine, and anti-FLAGM2 afﬁnity gels, andmousemono-
clonal antibodies (mAbs) to FLAG, talin, vinculin, and α-tubulin were
purchased from Sigma-Aldrich (St. Louis, MO). Rabbit polyclonal anti-
bodies (pAbs) to Akt and phospho-Akt (Ser473), and a rabbit mAb to
phospho-Akt substrate were purchased from Cell Signaling Technology
(Beverly, MA). Mouse mAbs to Myc and HA were obtained from Santa
Cruz Biotechnology (Santa Cruz, CA) and Covance (Richmond, CA),
respectively. A mouse IgM mAb to PIP2 was from Echelon Biosciences
(Salt Lake City, UT). A rabbit polyclonal antibody to PIP5Kγ90 and a
rabbit polyclonal antibody to phosphorylated PIP5Kγ90 at serine 555
residue were gifts from Pietro De Camilli (Yale University). Fetal bovine
serum (FBS) and penicillin/streptomycin were obtained from Hyclone
(Logan, UT). Lipofectamine 2000, goat serum, Texas-red phalloidin,
Alexa Fluor conjugated secondary antibodies, Opti-MEM I, and a rabbit
pAb to GFP were purchased from Invitrogen (Carlsbad, CA).
2.2. Expression constructs
GFP-, HA-, and His6-tagged human PIP5Kγ90 or PIP5Kγ87 cloned
into pEGFP-C2, pcDNA3-HA, and pET15 expression vectors, respectively,
were described previously [8,28]. pcDNA3-FLAG-PIP5Kγ90 (mouse
sequence) was a gift from Yasunori Kanaho (University of Tsukuba,
Japan). T553 and/or S555 in PIP5Kγ90 expression plasmidswasmutated
to alanine or aspartate by a QuikChange II Site-DirectedMutagenesis Kit
(Agilent Technologies) according to the manufacture's protocol. The
mutant plasmids were conﬁrmed by DNA sequencing (Genotech,
Daejeon, Korea). Active myr-Myc-Akt1 (#21-151) and mCherry-
paxillin (plasmid 50526) were purchased from Upstate Biotechnology
(Lake Placid, NY) and Addgene, respectively. All plasmids were puriﬁed
using an EndoFree Plasmid Maxi Kit (Qiagen, Hilden, Germany).
2.3. In vitro phosphorylation
Full-length His6-PIP5Kγ90 fusion proteins were expressed in
Escherichia coli strain BL21 and puriﬁed using Talon metal afﬁnity
resin (BD Biosciences), as described previously [28]. His6-PIP5Kγ90
fusion proteins (200 ng) were mixed with active, recombinant full-
length human Akt1 or Akt2 protein (Upstate Biotechnology) at a 1:1
stoichiometric ratio in the presence of 10 μCi γ-[32P]ATP (1 Ci =
37 GBq, PerkinElmer New England Nuclear radiochemicals) for up to
30 min at 30 °C. The phosphorylation reactions (30 μl ﬁnal volume)
were performed according to the manufacturer's protocol and stopped
by the addition of Laemmli sample buffer. Protein phosphorylation
was then analyzed by SDS-PAGE and autoradiography [35].
2.4. Cell culture, transfection and treatment
HeLa cells were grown in DMEM supplemented with 10% FBS and
penicillin/streptomycin at 37 °C in a humidiﬁed atmosphere of 5% CO2
and 95% air. Cells were grown up to 70–80% conﬂuence on 60 mm-
dishes for transient transfection. Expression plasmids of wild-type or
mutants of PIP5Kγ90 together with the indicated expression plasmids
or their relevant empty vectors as controls were mixed with Lipofecta-
mine 2000 in Opti-MEM I, and the mixtures were added to cells for
1 day. For Akt1 knockdown, mixtures of Akt1 siRNA (Santa Cruz
Biotechnology) and Lipofectamine RNAiMAX reagent (Invitrogen)
were added to cells for 1 day before PIP5Kγ90 transfection. Transfected
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for indicated times. In case of treatment of LY294002 (Biomol, Plymouth
Meeting, PA) and MK-2206 (Santa Cruz Biotechnology), the serum-
starved cells were preincubated in the presence and absence of the
inhibitors for 1 h prior to EGF treatment.
2.5. Western blotting and immunoprecipitation
Cells were harvested in a cell lysis buffer (50 mM Tris pH 7.4,
150 mM NaCl, 1 mM EDTA, 1 mM EGTA, 1 mM DTT, 1 mM Na3VO4,
5 mM NaF, and 1% Triton X-100) containing protease inhibitor cocktail
tablets (Roche) and lysed with a TissueLyzer II (Qiagen) for 2 min. For
the indicated experiments of talin–PIP5Kγ90 interaction (Fig. 3B), a
cell lysis buffer was supplemented with phosphatase inhibitor cocktail
3 (Sigma-Aldrich) instead of Na3VO4. After clearance by centrifugation
(15,000 ×g, 20 min, 4 °C), the protein concentration of the cell lysates
was determined using bicinchoninic acid protein assay reagents (Pierce,
Rockford, IL) as previously described [36]. For immunoprecipitation of
fusion proteins of GFP-PIP5Kγ90 and HA-PIP5Kγ90, cell lysates (0.5 to
1.0 mg) were incubated with 5 μg of anti-GFP and anti-HA antibodies,
respectively, for 4 h at 4 °C. Similarly, talin immunoprecipitation was
performed with the anti-talin antibody. The immune complexes were
capturedwith 20 μl proteinG agarose beads (Millipore) for an additional
2 h. Cell lysates (0.5 mg) expressing FLAG-PIP5Kγ90 were immuno-
precipitated by incubation with 20 μl anti-FLAG M2 afﬁnity gel for 2 h
at 4 °C. Immunoprecipitated samples were washed with the cell lysis
buffer 5 times. Equal amounts of proteins in cell lysates and immuno-
precipitates were separated by SDS-PAGE on 8–10% resolving gels
and transferred to nitrocellulose membranes (Schleicher & Schuell
Bioscience, Germany). Following blocking with 5% nonfat milk in TBS
containing 0.1% Tween-20 (TBST), membrane blots were incubated
with the corresponding primary antibodies for 2 h at room temperature
or overnight at 4 °C, washed thrice with TBST, and further incubated
with HRP-conjugated secondary antibodies (Zymed Laboratories, San
Francisco, CA). The resulting immune complexes were detected using
SuperSignal West Pico chemiluminescent substrate (Pierce, Rockford,
IL). Band intensities of Western blots were measured using NIH ImageJ
software (National Institutes of Health, Bethesda, MD).
2.6. Immunostaining and cell imaging
Cellswere plated onto 18-mmcircular coverslips coatedwithpoly-L-
lysine ~16 h prior to transfection of GFP-PIP5Kγ90 fusion proteins [36].
Twenty four hours post-transfection, cells were washed twice with
0.22-μm ﬁltered PBS and ﬁxed with 4% paraformaldehyde for 15 min
at room temperature. For talin and vinculin immunostaining, cells
were permeabilized with PBS containing 0.2% Triton X-100 for 15 min
and blocked for 30 min with PBS containing 10% BSA and 10% goat
serum. The inverted coverslips on impermeableNescoﬁlmwere stained
for 1 h at 37 °C with vinculin antibody diluted in the blocking buffer in a
humidiﬁed air-tight container, followed by staining for 1 h with Alexa
Fluor 594-conjugated secondary antibody. In case of PIP2 imaging,
PIP2 was immunostained by sequential incubation with the PIP2
mouse IgM mAb, biotinylated goat anti-mouse IgM (Jackson
ImmunoResearch Laboratories), and Alexa Fluor 594-conjugated
streptavidin (Invitrogen), as described previously [37]. F-actin was
stained with Texas-Red phalloidin diluted in PBS for 30 min. Cells
were washed with PBS between each staining step and ﬁnally washed
with distilled water and dried. Samples were mounted with Prolong
Gold Anti-fade Reagent (Invitrogen).
GFP ﬂuorescence and immunoﬂuorescence images were captured
with a Zeiss LSM 710 confocal microscope. The settings were as follows:
Plan-Apochromat 63× oil immersion objective lens was used with
405nmdiode laser at 10%output and 543nmHe/Ne laser at 80%output,
each of which was captured with band path 420–480 nm ﬁlter or long
path 560 nm ﬁlter, respectively. The thickness of the optical slice wasadjusted to 0.7 μm, and z-stacks were acquired at 50% overlap. The
acquisition conditions related to detector sensitivity were maintained
at the same level for quantitative analyses. Fluorescent intensities
were analyzed using the Zeiss ZEN imaging software. Cells immuno-
stained with talin antibody were visualized by total internal reﬂection
ﬂuorescence (TIRF) microscopy using Olympus IX-71 microscope ﬁtted
with a 100×, 1.45 NA TIRF-lens and controlled by CellM software
(Olympus). Diode lasers (488 and 561 nm) were coupled to the TIRF
microscopy condenser through two independent optical ﬁbers. The
angle of the incident laser was adjusted for the calculated penetration
depth of b120 nm. Cells were typically imaged either in a single channel
or in two channels by sequential excitation with 0.1 second exposures
and detected with a Andor iXon 897 EMCCD camera (512 × 512;
Andor Technologies, Belfast, Northern Ireland). Cell images were
analyzed with the ImageJ and MetaMorph (Molecular Devices, West
Chester, PA) software.
2.7. PIP2 ELISA measurements
Acidic lipids containing PIP2were prepared from total lipids extracts
of cultured cells and the amount of PIP2 was determined using the PIP2
Mass ELISA Kit (Echelon Biosciences) following the manufacturer's
protocol [36]. Absorbance at 450 nm was measured using a microplate
reader and PIP2 was quantiﬁed from a standard curve ﬁtted by
4-parameter nonlinear regression (SoftMax Pro, Molecular Devices).
2.8. GST fusion protein pull-down assay
The COOH-terminal regions of human PIP5Kγ90 cloned into pGEX-
6P-1 vector were expressed in E. coli strain BL21. GST fusion proteins
were prepared by afﬁnity puriﬁcation using glutathione-Sepharose
beads (Amersham Biosciences). After incubation with cell lysates
(0.5 mg) for 4 h at 4 °C, the beads were washed with PBS containing
0.1% Tween 20, and then analyzed by SDS-PAGE and immunoblotting
[28].
2.9. Cell migration assay
Cells expressing GFP-PIP5Kγ90 plasmids were pretreated with
0.5 μM mitomycin C (Sigma-Aldrich) for 2 h. After the culture media
were replaced with fresh complete media, cells were grown to a high
density and then scratched with plastic tips for creating cell wounds.
GFPﬂuorescent imageswere capturedusing anAxiovert 200M inverted
microscope equipped with LD Plan Neoﬂuar 40× objective and
AxioCam camera (Carl Zeiss Microimaging) at the beginning and 24 h
after treatment with EGF. FITC channel images were acquired with
AxioVision LE software (Carl ZeissMicroimaging). The extent ofmigrat-
ing cells toward cell wounds was determined by NIH ImageJ software.
2.10. Live imaging
Cells were cotransfected with GFP-PIP5Kγ90 and mCherry-paxillin
for 18 h, then replated onto 35 × 10 mm coverglass-bottom dishes
(SPL Life Sciences, Korea) coated with 30 μg/ml ﬁbronectin. Culture
media were replaced with fresh media after an additional incubation
for 8 h. Time-lapse imaging of GFP and mCherry ﬂuorescence was
performed with a Nikon A1R laser scanning confocal microscope. The
ﬂuorescent images were obtained at 1-min intervals up to 10 min.
2.11. Statistical analyses
All experiments were performed independently at least thrice with
similar results. Graphical data were presented as the mean ± S.E.
Statistical signiﬁcancewas determined using 1-way analysis of variance
(ANOVA) with Tukey's multiple comparison test using Graphpad
Software (San Diego, CA).
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3.1. Akt phosphorylates PIP5Kγ90 at serine 555 in vitro and cultured cells
We examined novel phosphorylations of PIP5Kγ90, a robust phos-
phoprotein [25,28]. The catalytic domain in the central regions is well
conserved among type I PIP5K family members, whereas the NH2- and
COOH-terminal regions are variable [27,38]. Interestingly, PIP5Kγ90
contains 2 Akt consensus phosphorylation sequences i.e., R-Y-R-R-R-T
and R-R-R-T-Q-S, in the COOH-terminal 548–555 amino acids where
threonine 553 (T553) and serine 555 (S555), the candidate residues
for Akt [30,32], are located in a tandem repeat fashion (Fig. 1A). Firstly,
we tested the possibility that PIP5Kγ90 is a substrate for in vitro Akt
phosphorylation reaction using recombinant active Akt proteins and
puriﬁed His6-tagged PIP5Kγ90 protein in the presence of 32P-labeled
ATP. As shown in the autoradiogram, Akt1 strongly phosphorylated
His6-PIP5Kγ90, and Akt2 also mediated similar His6-PIP5Kγ90 phos-
phorylation but to a lesser extent (Fig. 1B). Autophosphorylation of
Akt1 and Akt2 were also observed under the assay conditions. Auto-
phosphorylation of Akt2 was higher than that of Akt1, unlike theirFig. 1. Phosphorylation of PIP5Kγ90 by Akt at serine 555. (A) A domain structure of human PIP
puriﬁed His6-PIP5Kγ90 proteins substrates (each 200 ng) were incubated with the same amou
His6-PIP5Kγ90 fusion proteins were conﬁrmed by Coomassie brilliant blue (CBB) staining
(C) Phosphorylation levels of His6-PIP5Kγ90 T553A, S555A, and T553A/S555A mutants we
PIP5Kγ90 and autophosphorylated Akt1 or Akt2 were indicated by arrows and protein mol
conditions as (C), and analyzed by Western blotting with anti-phospho-Akt substrate (P-Akt
together with Myr-Myc-Akt1, as indicated. GFP IP products and cell lysates (input) were analy
α-Tubulin was included as a loading control.efﬁciencies for His6-PIP5Kγ90 phosphorylation (Fig. 1B). Speciﬁcity
was conﬁrmed by lack of radioactivities from incubation mixtures free
of Akt1 and Akt2.
In order to identify the target residues for Akt, T553 and/or S555
of His6-PIP5Kγ90 were mutated to non-phosphorylatable alanine.
The point mutant proteins were compared with wild-type (WT) His6-
PIP5Kγ90 protein for in vitro Akt phosphorylation efﬁciency. Autoradi-
ography showed that the T553A mutant was phosphorylated by Akt1
and Akt2 even more efﬁciently than WT (Fig. 1C). In contrast, both
S555A and T553A/S555Amutants were completely insensitive to phos-
phorylation by Akt1 and Akt2 (Fig. 1C), indicating that S555 is a major
phosphorylation site. Under the same conditions, we also measured
changes in these phosphorylations by Western blotting with a
phospho-Akt substrate antibody. This antibody speciﬁcally recognizes
phosphorylated serine or threonine in the R-X-R-X-X-S/T sequence
motif and thus has been widely used for detection of Akt substrates
[39,40]. Consistent with the autoradiography results, immunoreactiv-
ities of this antibody for WT and T553A mutant were much greater
than those for the single and double mutants harboring S555A
(Fig. 1D). Akt1 showed a much higher kinase activity for WT and5Kγ90 isoform containing Akt phosphorylation motifs. (B–D) For in vitro phosphorylation,
nts of recombinant active Akt1 or Akt2 under the indicated conditions. Equal amounts of
. (B) Phosphorylation levels of His6-PIP5Kγ90 WT were analyzed by autoradiography.
re compared with WT phosphorylation using autoradiography. (B, C) Phosphorylated
ecular weight markers. (D) Phosphorylation reactions were performed under the same
sub.) antibody. (E) HeLa cells were transfected with GFP-PIP5Kγ90 WT, T553A or S555A
zed by immunoblotting for transfected proteins and PIP5Kγ90 phosphorylation by Akt1.
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demonstrated that PIP5Kγ90 is preferentially phosphorylated by
Akt1 at S555 residue.
We then tested whether Akt1 could phosphorylate PIP5Kγ90 at
S555 in cultured cells. HeLa cells were cotransfected with WT, T553A
or S555A mutant of GFP-PIP5Kγ90 and the constitutively active
Akt1-Myc containing a NH2-terminal myristoylation sequence [41].
GFP-PIP5Kγ90 was immunoprecipitated with anti-GFP antibody
and its phosphorylated status was examined by Western blotting
with the phospho-Akt substrate antibody. Akt1-Myc strongly phos-
phorylated GFP-PIP5Kγ90 WT and T553A but not GFP-PIP5Kγ90
S555A mutant (Fig. 1E), consistent with the in vitro phosphorylation
results (Fig. 1C andD). Immunoblotting of cell lysates andGFP immuno-
precipitates with anti-GFP and/or anti-Myc antibodies conﬁrmed equal
expression levels of transfected proteins and immunoprecipitation (IP)
efﬁciency.
3.2. Activation of PI3K/Akt signaling by EGF induces PIP5Kγ90 S555
phosphorylation
We next examined the feasibility of in vivo PIP5Kγ90 S555 phos-
phorylation by endogenous Akt. PIP3 production by the class I PI3K at
the cell surface contributes to phosphorylation and activation of Akt
[31,32]. HeLa cells were stimulated by EGF, a potent activator of PI3K/
Akt signaling. Firstly, cell lysates were analyzed by immunoblotting for
phosphorylation of Akt at serine 473 (S473), which is widely used
as evidence of Akt activation. As expected, EGF treatment increased
S473 phosphorylation, which was inhibited by pretreatment with
LY294002, an inhibitor of PI3K (Fig. 2A). HeLa cells transfected with
FLAG-tagged PIP5Kγ90 were treated with EGF and/or LY294002, and
FLAG-PIP5Kγ90 was further puriﬁed from cell lysates by anti-FLAG IP.
Immunoblotting of FLAG IP products with the phospho-Akt substrate
antibody showed that EGF treatment increased Akt-dependent
PIP5Kγ90 phosphorylation, which was antagonized by LY294002 pre-
treatment (Fig. 2B). We tested effects of Akt inhibition on PIP5Kγ90
phosphorylation under the similar conditions. The EGF-induced
phosphorylated levels of PIP5Kγ90 were decreased by pretreatedFig. 2. EGF-induced PIP5Kγ90 S555 phosphorylation through PI3K/Akt signaling. Intact (A, F) o
or treated with EGF (100 ng/ml) for 20 min. (A) Cells were pretreated with vehicle (DMSO)
immunoblotting of total Akt (T-Akt) and phosphorylated Akt (P-Akt) at Ser473. (B–D) Cells tra
of EGF and 20 μM LY294002 (B) or 1 μM MK-2206 (C), an Akt inhibitor, for 1 h, as indicated
transfection. (E) Cells transfectedwith GFP-PIP5Kγ90WTor S555Awere treatedwith EGF for th
were analyzed by immunoblotting for transfected proteins and Akt-dependent PIP5Kγ90 phos
treatment and both samples were analyzed byWestern blotting with the indicated phospho-sMK-2206, an inhibitor of Akt (Fig. 2C). Akt1 knockdown with siRNA,
conﬁrmed by Western blot analysis of total Akt, also reduced
PIP5Kγ90 phosphorylation by EGF (Fig. 2D).
To ascertain that S555 phosphorylation is responsible for the EGF-
induced PIP5Kγ90 phosphorylation by Akt, cells transfected with GFP-
PIP5Kγ90 WT or S555A mutant were treated with EGF for 0, 15, 30,
and 60 min. Immunoreactive signals with the phospho-Akt substrate
antibody were detected in both cell lysates and GFP IP products from
WT-expressing cells, however, no such signal was detectable for up to
60 min in S555A-expressing cells (Fig. 2E). The immunoblotting results
of cell lysateswith the phospho-Akt substrate antibody reﬂectedmainly
Akt-mediated phosphorylation of transfected PIP5Kγ90, although other
potent Akt substratesmight also be detectable (Fig. 2B and E). It is likely
that relatively high PIP5Kγ90 expression on transfection could have an
overriding effect. Immunoreactivities of FLAG (Fig. 2B) andGFP (Fig. 2E)
in cell lysates and corresponding IP products conﬁrmed comparable
transfection and IP efﬁciency.
We further examinedwhether Akt could phosphorylate PIP5Kγ90 in
intact cells. Cells were treated with or without EGF and processed for
control IgG or PIP5Kγ90 IP and Western blotting. Equal amounts of
endogenous PIP5Kγ90 in input and IP products were conﬁrmed by
PIP5Kγ90 immunoblottings (Fig. 2F). Western blotting results of input
samples with a phospho-speciﬁc antibody to recognize phosphorylated
PIP5Kγ90 at S555, the phospho-Akt substrate antibody, and phospho-
Akt (S473) antibody demonstrated that Akt activation by EGF induced
S555 phosphorylation of endogenous PIP5Kγ90 (Fig. 2F). The similar
observation was made with immunoblotting of PIP5Kγ90 IP products
with the phospho-Akt substrate antibody (Fig. 2F). All these results
indicated that PIP5Kγ90 is a physiological substrate of Akt and S555 is
the main phosphorylation site in mammalian cells.
3.3. PIP5Kγ90 S555 phosphorylation negatively regulates the interaction of
PIP5Kγ90 with talin
We next examined whether S555 phosphorylation of PIP5Kγ90 can
affect the interaction with talin, the major cytoskeletal binding partner
for PIP5Kγ90. We utilized a phosphomimetic PIP5Kγ90 mutant withr transfected (B–E) HeLa cells were maintained in serum-free media for 6 h and untreated
or LY294002 (LY) for 1 h at the indicated conditions and cell lysates were processed for
nsfected with empty vector or FLAG-PIP5Kγ90 were incubated in the presence or absence
. (D) Control or Akt1 siRNA (60 pmol) was added to cells 1 day before FLAG-PIP5Kγ90
e indicated time period. FLAG IP (B–D) or GFP IP (E) products and respective input samples
phorylation. (F) PIP5Kγ90 IP products and cell lysates were prepared before and after EGF
peciﬁc antibodies. α-Tubulin blotting was included as a loading control.
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S555D mutant with WT for the talin binding afﬁnity. HeLa cells
transfected with GFP control vector, GFP-PIP5Kγ90 WT or S555D were
immunoprecipitated with GFP antibody. Talin immunoblotting showed
that endogenous talin coprecipitated with GFP-PIP5Kγ90 WT, as
expected (Fig. 3A) [8,9]. Interestingly, however, level of coprecipitated
talin was signiﬁcantly reduced by GFP-PIP5Kγ90 S555D (Fig. 3A). GFP-
PIP5Kγ90 WT, S555D or S555A mutant proteins were expressed and
GFP or talin IP products were evaluated for talin–PIP5Kγ90 binding, to
test whether the reduced talin binding afﬁnity of S555D mutant is
phosphorylation-dependent. Previous studies showed that tyrosine
649 phosphorylation by Src, tyrosine 654 phosphorylation, and tyrosine
639 phosphorylation by EGF receptor (human PIP5Kγ90 sequence)
positively mediated the interaction with talin [19,42]. We used a cell
lysis buffer containing an inhibitor cocktail of serine/threonine protein
phosphatases and free of Na3VO4, an inhibitor of protein tyrosine phos-
phatases, to simply exclude possible implications of such tyrosine phos-
phorylation events of PIP5Kγ90. Coprecipitated talin andGFP-PIP5Kγ90
in GFP and talin IP products, respectively, were quantiﬁed. Immunoblot-
ting of GFP IP products with talin showed that transfected S555A
retained talin binding afﬁnity to a similar level as WT, while S555D
did not (Fig. 3B and C). Likewise, GFP immunoblotting of talin IP
products from the same transfected samples showed that coprecipitation
of the S555Dmutant was less thanWT, but S555Amutant coprecipitated
almost equally (Fig. 3B and C). Expression and IP efﬁciency of the
transfected GFP-PIP5Kγ90 fusion proteins and endogenous talin wereFig. 3. Inhibitory effect of PIP5Kγ90 S555 phosphorylation on its interaction with talin. (A, B) H
indicated. (B) Cells were lysed in a buffer with serine/threonine protein phosphatase inhibitor
contents of transfected proteins and talin in the IP products and corresponding input samples w
GFP. (C) The band intensities of coprecipitated talin andGFP-PIP5Kγ90 proteins in each immuno
S.E. *p b 0.05. (D)GST fusion proteins of PIP5Kγ90CT regionWT, S555DorGST control protein co
onWestern blotting, and equal amount of bait proteinswas revealed by CBB staining. (E, G) HeL
After serum starvation for 6 h, cells were treated with EGF (100 ng/ml) for the indicated time
proteins, talin, and Akt-dependent phosphorylation in the IP products and corresponding inp
Akt substrate and anti-talin blots in the GFP IP in (E) were measured and quantiﬁed as fold ch
α-Tubulin blotting was included as a loading control.conﬁrmed by immunoblotting with corresponding antibodies (Fig. 3A
and B). We introduced this mutation into glutathione S-transferase
(GST) fusion protein of the COOH-terminal (CT) region of PIP5Kγ90
(459–668 amino acids) that was previously used for talin–PIP5Kγ90
interaction [8], to further evaluate the reduced talin binding afﬁnity of
PIP5Kγ90 S555D mutant. A control GST protein and GST fusion proteins
of PIP5Kγ90 CT WT or S555D conjugated to glutathione beads were
used in talin pull-down assaywith HeLa cell lysates. Similar to the results
from GFP IP samples (Fig. 3A–C), S555D had relatively weak talin immu-
noreactivity in comparison with WT, and GST alone showed no such
signal (Fig. 3D).
PIP5Kγ90 S555 is phosphorylated upon EGF stimulation via PI3K/Akt
signaling (Fig. 2). We thus determined whether PIP5Kγ90 interaction
with talin is negatively regulated following Akt activation by EGF.
HeLa cells transfected with GFP-PIP5Kγ90 WT were exposed to EGF
time dependently, and the levels of phosphorylated PIP5Kγ90 and
coprecipitated talin in GFP IP products were evaluated by immunoblot-
ting with respective antibodies and quantiﬁcation of the immunoreac-
tivity. The talin binding afﬁnities of PIP5Kγ90 gradually decreased,
which was in striking contrast to time-dependent increases in
Akt-mediated PIP5Kγ90 phosphorylation (Fig. 3E and F). Unlike GFP-
PIP5Kγ90 WT, binding of transfected GFP-PIP5Kγ90 S555A that could
not be phosphorylated by Akt was able to bind talin in EGF-stimulated
cells (Fig. 3G). These results indicated that Akt-dependent PIP5Kγ90
S555 phosphorylation prevents talin–PIP5Kγ90 interaction in physio-
logical conditions such as EGF stimulation.eLa cells were transfected with GFP-PIP5Kγ90WT, S555D, S555A or GFP control vector, as
s and without Na3VO4. Cell lysates were processed for GFP IP (A, B) or talin IP (B). Protein
ere detected by immunoblotting. Arrows in (A) indicate GFP-PIP5Kγ90 fusion proteins or
precipitate in (B)were quantiﬁed relative toWT samples. Values are presented asmean±
njugated to glutathionebeadsweremixedwithHeLa cell lysates. Bound talinwasdetected
a cells were transfectedwith GFP-PIP5Kγ90WT, S555A, or GFP control vector, as indicated.
(E) or for 20 min (G), then GFP IP products were prepared. Protein levels of transfected
ut samples were detected by immunoblotting. (F) The band intensities of anti-phospho-
anges relative to those zero-time samples. Values are presented as mean ± S.E. *p b 0.05.
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PIP2 levels
PIP5Kγ90 is targeted to FAs due to its interaction with talin [8,9].
Because talin–PIP5Kγ90 interaction was impaired by S555 phosphory-
lation of PIP5Kγ90, we tested whether the S555 phosphorylation
could affect localization of PIP5Kγ90 to FAs. We used HeLa cells
transfected with GFP-PIP5Kγ90 WT, S555D or S555A, and visualized
FAs by talin immunostaining and TIRF microscopy. Consistent with
previous demonstrations, PIP5Kγ90 WT speciﬁcally localized to FAs, as
shown by the robust colocalization with talin (Fig. 4A) [8,9]. Notably,
while GFP-PIP5Kγ90 S555A still had prominent colocalization with
talin, GFP-PIP5Kγ90 S555Ddid not (Fig. 4A), whichwas in a good agree-
ment with the biochemical interaction results (Fig. 3B and C). Fluores-
cent intensity proﬁles of GFP and talin further revealed a close match
between WT or S555A mutant and talin but a relatively signiﬁcant
mismatch between S555D mutant and talin (Fig. 4B).
The binding of talin to PIP5Kγ90 exerted a stimulatory effect on its
kinase activity, inducing increase in PIP2 levels [8]. We thus examined
whether plasma membrane PIP2 level can be modulated by PIP5Kγ90
S555 phosphorylation. We evaluated differences in PIP2 levels using
immunostaining and ﬂuorescence intensity analysis of PIP2 in HeLa
cells transfected with GFP-PIP5Kγ90 WT, S555D or S555A. The PIP2
confocal images showed that PIP2 concentration, in general, was
proportional to the extent of transfection in the GFP-PIP5Kγ90 WT- or
S555A-expressing cells (Fig. 4C and D). However, under similar trans-
fection efﬁciency and expression levels, the PIP2 concentration was
relatively much lower in GFP-PIP5Kγ90 S555D-expressing cells
(Fig. 4C and D).We also determined PIP2 amounts in total lipid extracts
from the same transfected cells by an ELISA method. Similar to the
results of PIP2 immunoﬂuorescence, PIP2 levels were signiﬁcantly
reduced in S555D-expressing cells, as compared with WT- or S555A-
expressing cells (Fig. 4E). These results indicated that PIP5Kγ90 S555Fig. 4. Loss of colocalization of PIP5Kγ90 S555D with talin leading to decrease in PIP2 level. (
immunostained with antibody to talin (A) or PIP2 (C), followed by Alexa Fluor 594-labeled
Scale bars, 10 μm (top), 2 μm(bottom). (B) Fluorescent intensities of talin and GFP from thema
represent the intensity proﬁles along the lines in (A). (C) PIP2 ﬂuorescence was visualized b
quantiﬁed relative to those from WT. Values are presented as mean ± S.E. *p b 0.05. (E) Cellu
and quantiﬁed relative to those fromWT. Values are presented as mean ± S.E. *p b 0.05.phosphorylation leads to its dislocation from FAs and decreases in
PIP2 levels.
3.5. EGF-induced S555 phosphorylation of PIP5Kγ90, but not of PIP5Kγ87,
speciﬁcally reduces talin binding and PIP2 levels
PIP5Kγ87 isoform does not bind talin due to the absence of the
28-amino acid tail motif that is expressed in PIP5Kγ90 [8,9]. As S555 is
also present in PIP5Kγ87, we determined Akt-mediated phosphoryla-
tion of PIP5Kγ87. HeLa cells transfected with HA-tagged PIP5Kγ87 or
PIP5Kγ90 treated with or without EGF were processed for HA IP. As
shown by the phospho-Akt substrate immunoblotting, not only
PIP5Kγ90 but PIP5Kγ87 was phosphorylated by Akt upon EGF stimula-
tion (Fig. 5A). As expected, however, coprecipitated talin was not
detectable irrespective of EGF stimulation in HA-PIP5Kγ87 IP samples
unlike the decreased talin binding of HA-PIP5Kγ90 by the presence of
EGF (Fig. 5A). We then examined effects of Akt-mediated phosphoryla-
tion of PIP5Kγ87 and PIP5Kγ90 on PIP2 levels. HeLa cells transfected
with GFP control vector, GFP-PIP5Kγ87 WT, GFP-PIP5Kγ90 WT or
GFP-PIP5Kγ90 S555A were challenged in the presence and absence of
EGF and changes in PIP2 levels were visualized by immunostaining. In
unstimulated conditions, PIP2 levels were elevated by transfections of
all tested PIP5Kγ constructs, as compared with control cells (Fig. 5B),
which is probably due to their retained lipid kinase activities. EGF
stimulation hardly induced changes in PIP2 levels in control and GFP-
PIP5Kγ87 WT-expressing cells, but caused signiﬁcant reductions in
PIP2 levels in GFP-PIP5Kγ90 WT-expressing cells (Fig. 5B). No signiﬁ-
cant changes in PIP2 levels were detected on EGF stimulation in
GFP-PIP5Kγ90 S555A-expressing cells (Fig. 5B). Under similar condi-
tions, talin binding afﬁnities of PIP5Kγ90 WT, but not of PIP5Kγ90
S555A mutant, were reduced (Fig. 3G). These results indicated that
PIP5Kγ90-dependent PIP2 pool is speciﬁcally regulated through talin
binding in EGF-stimulated cells.A, C, E) HeLa cells were transfected with GFP-PIP5Kγ90 WT, S555D or S555A. Cells were
secondary antibody. (A) The ﬂuorescent images were obtained using TIRF microscopy.
gniﬁed inset images in (A) were quantiﬁedwithMetaMorph imaging software. The graphs
y confocal microscopy. (D) The PIP2 ﬂuorescence intensities in (C) were measured and
lar PIP2 levels from extracted acidic lipids were measured using the PIP2 mass ELISA kit
Fig. 5. Differential effects of Akt-mediated phosphorylation of PIP5Kγ87 and PIP5Kγ90 on talin binding and PIP2 production following EGF treatment. (A) HeLa cells transfected with
HA-PIP5Kγ87 or HA-PIP5Kγ90 were serum starved for 6 h, then untreated or treated with EGF (100 ng/ml) for 20 min. Cells were processed for HA IP and resulting cell lysates and IP
samples were analyzed by Western blotting for transfected proteins, talin, and Akt-dependent phosphorylation. (B) HeLa cells transfected with GFP-PIP5Kγ87, GFP-PIP5Kγ90 WT or
S555A, or GFP control vector were treated with or without EGF as described in (A). Cells were immunostained with anti-PIP2 antibody and Alexa Fluor 594-labeled secondary antibody.
The GFP and PIP2 ﬂuorescence was visualized by confocal microscopy. Scale bar, 10 μm.
2439O.T.T. Le et al. / Biochimica et Biophysica Acta 1853 (2015) 2432–24433.6. PIP5Kγ90 S555Dmutant downregulates formations of stress ﬁbers and
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The cell-matrix adhesion sites, FAs, are associated with actin
ﬁlament bundles called stress ﬁbers [43]. PIP2 is an important inducer
of actin polymerization and alterations in PIP2 levels control actin
stress ﬁber formation [24,27]. As S555 phosphorylation of PIP5Kγ90
decreased PIP2 levels (Figs. 4C and 5B), we examined whether this
phosphorylation affects actin stress ﬁbers by ﬂuorescent phalloidin
staining. The intensities of stress ﬁbers were remarkably attenuated in
GFP-PIP5Kγ90 S555D-expressing cells, as compared to GFP-PIP5Kγ90
WT-expressing cells (Fig. 6A), suggesting that the S555 phosphorylation
of PIP5Kγ90 negatively regulates stress ﬁber formation. We next
addressed whether this phosphorylation might regulate FA stability.HeLa cells transfectedwith GFP-PIP5Kγ90WT or S555Dwere visualized
by vinculin immunostaining, a well-known FA marker protein
[44]. Consistent with their colocalization with talin (Fig. 4A and B),
confocal images showed that while GFP-PIP5Kγ90 WT speciﬁcally
colocalized with vinculin, colocalization of GFP-PIP5Kγ90 S555D with
vinculin was relatively less signiﬁcant (Fig. 6B). Detailed analysis of
those images clearly showed such differences in FA localizations
between WT and S555D (Fig. 6C). Furthermore, we found that the
S555D mutant caused prominent loss of relatively large and stable
vinculin-positive FAs, as compared to WT (Fig. 6B). Image analysis
of vinculin-containing FAs indicated that the S555D mutant led to
signiﬁcant reductions in numbers of FAs with various lengths
(Fig. 6D), suggesting that PIP5Kγ90 S555 phosphorylation results in
disassembly of FAs.
Fig. 6. Decreases in stress ﬁbers and vinculin-positive FAs induced by PIP5Kγ90 S555D expression. (A, B) HeLa cells were transfected with GFP-PIP5Kγ90WT or S555D. (A) Stress ﬁbers
were visualized by Texas-red phalloidin staining and confocal microscopy. (B) For visualization of FAs, cells were immunostainedwith anti-vinculin antibody and Alexa Fluor 594-labeled
secondary antibody. Cell images were captured using confocal microscopy. Scale bars, 10 μm. (C) GFP and vinculin ﬂuorescent intensities from the magniﬁed inset images in (B) were
quantiﬁed with the Zeiss ZEN imaging software. The graphs represent the intensity proﬁles along the lines. (D) Vinculin-containing FAs in more than 20 cells were counted according
to a classiﬁcation of different lengths. Values are presented as mean ± S.E. *p b 0.05.
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assembly and disassembly
Migrating cells undergo complex processes of continuous cycles of
FA assembly and disassembly [10,11]. As PIP5Kγ90 S555D mutant
apparently reduced stress ﬁbers and stable FAs (Fig. 6), we examined
the possibility that PIP5Kγ90 S555 phosphorylation can modulate cell
motility using a wound healing assay. For this purpose, we compared
PIP5Kγ90 WT and its non-phosphorylatable S555A mutant for their
effects on cell migration under the EGF-stimulated condition.
Transfected cells were treated with mitomycin C prior to cell wounding
to rule out possible interfering effects of the transfected proteins on cell
proliferation. GFP ﬂuorescent images taken 24 h after EGF treatment
showed that HeLa cells expressing GFP-PIP5Kγ90 WT migrated faster
than cells expressing GFP-PIP5Kγ90 S555A (Fig. 7A and B). Next, we
examined the effect of PIP5Kγ90 phosphorylation on FA assembly and
disassembly by monitoring changes in paxillin. Live cell imaging with
paxillin has been used for studies on FA dynamics in cultured cells
[18,45]. For this purpose, HeLa cells were cotransfected with GFP-
PIP5Kγ90 WT, S555D or S555A with mCherry-paxillin, and GFP and
mCherryﬂuorescent imageswere collected using time-lapsemicroscopy
(Fig. 7C). Of note, more rapid FA assembly and disassemblywas found in
cells expressing GFP-PIP5Kγ90 S555D, while FAs were relatively stable
in the cells expressing GFP-PIP5Kγ90 WT and S555A (Fig. 7C and D).
As emphasized by the indicted arrows, these results suggested that
PIP5Kγ90 S555 phosphorylation enhances cell motility by promoting
FA turnover rates.
4. Discussion
Accumulating evidence shows that each PIP5K isoform has speciﬁc
subcellular localizations, and distinct binding partner proteins and func-
tions [5,27]. In general, due to these unique characteristics, individual
PIP5Ks are believed to differentially control a speciﬁc pool of plasma
membrane PIP2 under certain circumstances [46]. Hence, it is important
to understand how the PIP5K isoform-speciﬁc PIP2 production is
regulated on target membranes [46,47]. Numerous studies have soughtto elucidate various molecular mechanisms responsible for alterations
in PIP5Ks' enzymatic functions. For example, protein phosphorylation
of PIP5Ks or interaction with their binding partner proteins changes
their catalytic activities [27,38]. We identiﬁed the exclusive presence
of Akt consensus motifs in PIP5Kγ90 and investigated the physiological
relevance of PIP5Kγ90 phosphorylation by Akt and its functional role in
talin binding and FA dynamics.
We showed that PIP5Kγ90 is a novel substrate for Akt. S555 is a
major phosphorylation residue and is more selective for Akt1 than
Akt2 under in vitro assay conditions. In fact, T553, another residue
matching the Akt consensus sequence, is totally insensitive to Akt,
indicating the speciﬁcity of S555 phosphorylation by Akt1. We also
conﬁrmed that PIP5Kγ90 S555 phosphorylation is a downstream
event of PI3K/Akt signaling activated by EGF. Our results indicated
that PIP5Kγ90 S555D mutant bound talin less efﬁciently and was less
concentrated at FAs, unlike the S555A mutant. Thus, Akt activation can
abrogate the FA localization of PIP5Kγ90 by mediating the inhibitory
S555 phosphorylation for talin binding. The amounts of PIP5Kγ90
bound to talin in resting cells were time-dependently decreased upon
EGF stimulation concurrent with gradual increases in the S555 phos-
phorylation levels. It is plausible that activated Akt phosphorylates a
pool of PIP5Kγ90 preassembled with talin, dissociating the protein
assembly or a pool of cytoplasmic PIP5Kγ90, consequently limiting its
accessibility to talin. Our results also showed that PIP5Kγ90-, but not
PIP5Kγ87-dependent PIP2 levels were decreased by EGF, and similar
changes were observed with PIP5Kγ90 S555D mutant, but not the
S555A mutant. Apparently, S555 phosphorylation of PIP5Kγ90 induced
by EGF stimulation or mimicked by the S555D expression resulted in
relatively low PIP2 levels and weaker talin–PIP5Kγ90 interaction.
Thus, it is reasonable that the changes in the PIP5Kγ90-dependent
PIP2 pool are driven by the extent of talin binding rather than by phos-
phorylated status of S555 itself. Overall, our observations corroborated
the known roles for talin in the recruitment of PIP5Kγ90 to FAs and
induction of its enzymatic activation [8].More importantly, these results
suggested that the Akt-mediated S555 phosphorylation can serve as a
signal for controlling local PIP2 levels at the FAs through regulation of
talin–PIP5Kγ90 interaction.
Fig. 7. Enhanced cell migration and FA dynamics by PIP5Kγ90 S555 phosphorylation. (A) HeLa cells transfected with GFP-PIP5Kγ90 WT or S555A were incubated in a culture medium
containing 0.5 μMmitomycin C for 2 h, washed and replaced with fresh media. Cell wounds were then made and migration of transfected cells was visualized with a ﬂorescence micro-
scope at 0 and 24 h after 100 ng/ml EGF treatment. (B) The extent of EGF-induced cell migration in (A) was quantiﬁed as fold changes relative to S555A at 24 h. Values are presented as
mean ± S.E. *p b 0.05. (C, D) HeLa cells were transfected with GFP-PIP5Kγ90 WT, S555D, or S555A together with mCherry-paxillin. (C) Time-lapse imaging of GFP and mCherry was
performed using confocal microscopy, as described in Materials and methods section. Arrows highlight differences in dynamics of FA assembly and disassembly among the expressed
PIP5Kγ90 proteins. (D) The rates of FA assembly and disassembly represented by the mCherry-paxillin ﬂuorescence were determined from more than 30 cells and quantiﬁed relative
to those fromWT. Values are presented as mean ± S.E. *p b 0.05.
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phorylation of PIP5Kγ87 presumably at S555, but only PIP5Kγ90 S555
phosphorylation had a functional effect on the talin binding. Our results
supported the idea that the S555 phosphorylation of PIP5Kγ90 inter-
feres with the assembly of the F3 subdomain of talin FERM domain
and the 28-amino acid tail of PIP5Kγ90 [8]. However, the underlying
mechanism is currently unclear as the S555 is not located in the talin
binding interface. It has been shown that talin binding of PIP5Kγ90 is
differentially regulated depending on the speciﬁc residues being phos-
phorylated. It was demonstrated that Cdk5-mediated phosphorylation
of PIP5Kγ90 at serine 650 (S650) in theminimal talin binding sequence
(WVYSPL, 647–652 amino acids) within the 28-amino acid tail blocks
its interaction with talin [28,48]. In contrast, it was reported that Src-
mediated phosphorylation of the adjacent tyrosine 649 (Y649), which
is facilitated by FAK, enhances talin binding [42]. Interestingly, our
previous ﬁndings indicated that the phosphorylation of Y649 and
S650 has an antagonizing effect on the phosphorylation of S650 and
Y649, respectively [28]. In some cases of multiple phosphorylations of
a target substrate through distinct protein kinases, individual phosphor-
ylation reactions are related to each other in a positively or negatively
cooperative manner [49,50]. These protein kinases are active players
of growth factor signalings associated with cytoskeletal regulation and
involved in Akt pathway [34,51–54]. In this regard, our present results
implicate that S555 phosphorylation by Akt may indirectly modulate
the phosphorylation of Y649 and/or S650 by crosstalk with other
pathways like Cdk5 and Src. If this is the case, S555 phosphorylation
may result in changes in phosphorylated levels of Y649 and/or S650 in
such a way to disassemble talin–PIP5Kγ90 complex. In addition, S555
phosphorylated PIP5Kγ90 may interact with unidentiﬁed proteins,
consequently making talin binding unfavorable. On the other hand,
various cytoskeletal proteins undergo conformational transition
between active and inactive forms. Alternatively, we thus cannotexclude the possibility that Akt-mediated S555 phosphorylation may
induce an autoinhibitory conformation change leading to a masking of
the talin binding motif in PIP5Kγ90. The precise coordination of how
S555 phosphorylation negatively regulates talin binding remains to be
further investigated.
Several lines of evidence indicate that changes in plasmamembrane
PIP2 levels are related to stress ﬁber formation. PIP2 sequestration by
PLCδ pleckstrin homology domain or PIP2 degradation by PIP2
5-phosphatase expression led to a decrease in actin stress ﬁbers [55],
whereas PIP2 production by PIP5K overexpression increased actin stress
ﬁbers [56]. It has also been shown that the type I PIP5Ks act as down-
stream effectors of Rho family small GTPase signaling pathways,
among which RhoA activation contributes to stress ﬁber formation
[27,57–59]. Phosphorylation of PIP5Kγ90 by Cdk5 and its activator
p35, thus inhibiting its interaction with talin, was shown to cause a
disruption of stress ﬁbers [28]. In this study, actin stress ﬁbers were
signiﬁcantly less pronounced on S555D expression. The results of
decreased PIP2 levels in these cells indicate an apparent correlation
between PIP2 levels and stress ﬁber formation. Therefore, Akt-
regulated PIP5Kγ90–talin binding can modulate PIP2-dependent stress
ﬁber formation.
FAs are relatively large and stable, as compared to nascent adhesion
and focal contact sites that are actively formed near the leading edge
of motile cells undergoing membrane protrusions [60]. The higher
magnitude and strength of FAs, in general, have a negative impact on
cell motility. Vinculin is present at cell adhesion sites with more prom-
inent localization to FAs. Previously, mouse embryonic ﬁbroblasts
deﬁcient in vinculin migrated faster and exhibited less stable FAs and
more dynamic FA turnover, as compared toWT [61], while PIP2 binding
could activate vinculin. Activation of PLCβ, an enzyme to degrade PIP2,
is involved in the bradykinin-induced selective dissipation of vinculin-
positive FAs and reorganization of stress ﬁbers [62]. Here, we observed
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sizes of vinculin-positive FAs, indicating a destabilizing effect of
this phosphorylation on FAs. We also found that PIP5Kγ90 S555D
expression increased the turnover rate of paxillin-positive FAs and
that PIP5Kγ90 WT expression enhanced cell migration more
signiﬁcantly than S555A expression in the EGF-stimulated condition.
Appearance of robust stress ﬁbers is indicative of FA maturation and
maintenance [63,64]. Together with the reduced stress ﬁbers by the
S555D mutant, our results suggested that local decrease in PIP2 levels
at FAs through PIP5Kγ90 S555 phosphorylation by Akt leads to FA
disassembly, thereby promoting cell migration.
Recent biochemical and structural studies of the tertiary complex of
talin, integrin and PIP2 have provided more detailed aspects of their
interactions. PIP2 interaction with the talin head FERM domain results
in activation by relieving the autoinhibited conformation between its
head and rod domains; and the binding of talin F3 subdomain to
β-integrin that induces dissociation of inhibitory integrin α/β tail com-
plex is associated with the PIP2 binding to the talin F2 subdomain
[65–68]. Accordingly, PIP2 binding to talin enhances its binding afﬁnity
for β-integrin tail and also mediates its recruitment to FAs [69].
PIP5Kγ90-deﬁcient ﬁbroblasts lacking FA-speciﬁc PIP2 production
have defects in integrin–actin force coupling due to reduced incorpora-
tion of talin and vinculin into FAs [17]. Similarly, PIP2 binding induces
vinculin activation through disruption of its inhibitory head-to-tail
interaction [61]. On the other hand, FA-localized PIP5Kγ90 can also
negatively regulate talin–integrin interaction through competition
with integrin for talin binding, inducing transdominant inhibition of
integrin activation [21,22,70]. Previous reports and our results collec-
tively indicate that transfected PIP5Kγ90 is potentially targeted to FAs
and activated via interaction with talin allowing increase in FA-speciﬁc
PIP2 levels, which can, in turn, activate talin, and possibly vinculin,
and recruit them to FAs. Such effects of PIP5Kγ90 on integrin-based
FA formation can be counterbalanced by its inhibitory effect on talin–
integrin interaction. Upon EGF stimulation, Akt-mediated phosphoryla-
tion of PIP5Kγ90 at S555 that induces its dissociation from talin
complex may facilitate integrin activation by releasing its inhibitory
effect on talin–integrin assembly.
Regulation of local PIP2 synthesis by PIP5Kγ90 affects FA dynamics
[10,16]. PIP5Kγ90-dependent PIP2 production was required for
EGF-induced migration in HeLa cells, where EGF receptor-mediated
PIP5Kγ90 tyrosine phosphorylation induced dissociation of PIP5Kγ90–
PLCγ interacting complex, resulting in PIP2 accumulation, which
contributed to PIP2-dependent talin assembly into cell adhesions [19].
Compared to PIP5Kγ90 WT, its catalytically inactive mutant reduced
the rates of FA assembly and disassembly in CHO-K1 cells [20]. On the
other hand, ubiquitination and subsequent degradation of PIP5Kγ90
by HECDT1 ubiquitin ligase promoted FA assembly and disassembly
in MDA-MB-231 cells, thereby enhancing cell migration, and an
ubiquitination-resistant mutant form of PIP5Kγ90 or HECDT1 knock-
down that caused increases in PIP2 levels inhibited FA assembly and
disassembly [18]. High levels of PIP5Kγ90 by overexpression disorga-
nized FAs [8,9]. Thus, it is likely that the strict control of PIP5Kγ90-
dependent PIP2 pool within an optimal range is critical for FA dynamics
underlying cell motility. A previous report demonstrated that plasma
membrane PIP2 levels correlates with cell adhesion strength and
decreases in PIP2 levels induce membrane blebs [55], which is often
found in motile cells including invasive cancer cells [71]. PIP5Kγ90
genetic ablation in mouse megakaryocytes also showed similar
membrane bleb formation [72]. PIP2 5-phosphatase expression or PLC
activation by growth factors that mediated PIP2 hydrolysis decreased
membrane–cytoskeleton adhesion [55,73]. The accumulation of
PIP2 at FAs may also render adhesion strength to remain at high levels
and to generate excessive force, resulting in retardation of cell motility.
Hence, it is possible that signaling pathways to downregulate PIP5Kγ90-
dependent PIP2 levels are also necessary for rapid FA dynamics during
cell migration. In this context, our results suggested that Akt-mediatedPIP5Kγ90 phosphorylation that is accompanied by decreases in PIP2
levels due to reduced talin assembly, and increases in FA dynamics
can, at least in part, serve as such a regulatory mechanism.
5. Conclusion
Cytoskeletal protein networks of FAs are regulated via multiple
signaling pathways in response to extracellular stimuli. The control of
PIP2 level is one of the critical factors that coordinate FA dynamics.
PIP5Kγ90 mediates PIP2 production at FAs where its location and
activation is associated with talin binding. We demonstrated that
PIP5Kγ90 is speciﬁcally phosphorylated at S555 by Akt upon EGF
stimulation in a PI3K-dependent manner. The S555 phosphorylation
of PIP5Kγ90 impedes its interaction with talin. Accordingly, this
phosphorylation induces mislocalization of PIP5Kγ90 to FAs and conse-
quently decreases in PIP2 levels. The talin-dependent PIP2 production is
mediated speciﬁcally by PIP5Kγ90 but not PIP5Kγ87. Furthermore,
PIP5Kγ90 S555 phosphorylation results in reduction in stress ﬁbers
and stable FAs, which promotes FA disassembly and thus cell migration.
Taken together, our results demonstrate a novel link of Akt signaling
in the regulation of talin–PIP5Kγ90 interaction that can ultimately
modulate FA dynamics and cell motility.
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